In acute ST‑segment‑elevation myocardial infarction, what are the recommended target door‑to‑balloon (DTB) and door‑to‑needle (DTN) times?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Door-to-Balloon and Door-to-Needle Time Targets in STEMI

For primary PCI, achieve door-to-balloon time ≤90 minutes; for fibrinolytic therapy, achieve door-to-needle time ≤30 minutes.

Primary PCI: Door-to-Balloon Time ≤90 Minutes

The 2017 ESC Guidelines establish that primary PCI-capable centers must deliver 24/7 service and perform primary PCI without delay 1. While the guidelines emphasize performing PCI "without delay," the established international benchmark is ≤90 minutes from first medical contact (door time) to balloon inflation.

The 2013 ACC/AHA guidelines provide critical context: when interhospital transfer is required, primary PCI should be performed within 120 minutes of first medical contact 2. Beyond this 120-minute threshold, the survival advantage of primary PCI over fibrinolysis is negated. This occurred in nearly half of transferred patients analyzed, underscoring the importance of realistic time goals.

Evidence Supporting the 90-Minute Target

Recent real-world data confirms this benchmark is achievable and clinically meaningful:

  • A 2026 Indian tertiary center audit demonstrated 91% of patients achieved DTB ≤90 minutes (mean 76±9.4 minutes), meeting international standards 3
  • The 2025 Saudi STARS-2 registry showed 75.6% achieved DTB <90 minutes with a median of 63 minutes 4
  • Implementation of STEMI networks significantly reduces DTB times, with one U.S. study showing marked improvement after network establishment 5

Critical nuance: A 2017 analysis questions whether shortening DTB beyond current recommendations improves outcomes 6. Overly aggressive DTB reduction may lead to false-positive STEMI interventions and missed alternative diagnoses. The 90-minute target represents an evidence-based balance between speed and diagnostic accuracy.

Fibrinolytic Therapy: Door-to-Needle Time ≤30 Minutes

When primary PCI cannot be performed within the recommended timeframes, fibrinolytic therapy should be administered within 30 minutes of hospital arrival 2. The ESC guidelines state fibrinolysis should be initiated "as soon as possible after STEMI diagnosis, preferably in the pre-hospital setting" 1.

The 2025 Saudi registry revealed only 57% achieved DTN <60 minutes with a median of 25 minutes 4, suggesting the 30-minute target is challenging but represents best practice.

When to Choose Fibrinolysis Over Transfer for PCI

Fibrinolytic therapy is recommended when:

  • Transfer delays would exceed 120 minutes from first medical contact to balloon inflation 2
  • Patient presents within 2-3 hours of symptom onset with low bleeding risk
  • No contraindications exist

Patients best suited for immediate transfer to PCI (bypassing fibrinolysis):

  • Cardiogenic shock or high-risk features
  • High bleeding risk
  • Presentation >3-4 hours after symptom onset with short transfer times
  • Late presentation where fibrinolysis efficacy is reduced

Practical Implementation Strategies

Reducing Door-to-Balloon Delays

The ACC/AHA guidelines identify key system factors for achieving optimal DTB times 2:

  1. Senior management commitment to explicit DTB improvement goals
  2. Direct catheterization lab transfer - bypass emergency department when possible 1
  3. Prehospital ECG transmission from ambulances significantly improves times 7
  4. Collaborative team culture with uncompromising clinical leadership
  5. Real-time data feedback to monitor and address delays

Common Delay Factors to Address

Patient-related delays (consent issues account for 31-48% of delays) 3, 8:

  • Streamline consent processes
  • Educate patients during triage

Hospital-related delays 3, 8:

  • Catheterization lab occupancy (14%)
  • Diagnostic ambiguity (14-30%)
  • Need for hemodynamic stabilization (32%)

Critical caveat: A 2023 Russian registry found that DTB time reduction only improved outcomes when prehospital delay was ≤120 minutes 9. When patients presented >120 minutes after symptom onset, shorter DTB times did not influence outcomes. This emphasizes that total ischemic time matters more than any single interval - prehospital delay correlates strongly with total ischemic time (r=0.87), while DTB time shows only moderate correlation (r=0.41).

Algorithmic Approach

For patients presenting to PCI-capable center:

  • Target DTB ≤90 minutes
  • Activate catheterization lab immediately upon STEMI diagnosis
  • Bypass emergency department when feasible

For patients at non-PCI-capable hospital:

  • Can transfer achieve PCI within 120 minutes of first medical contact?
    • Yes → Transfer immediately for primary PCI
    • No → Administer fibrinolysis within 30 minutes (if no contraindications), then transfer for angiography at 2-24 hours

Special populations requiring immediate transfer regardless of time:

  • Cardiogenic shock
  • High bleeding risk for fibrinolysis
  • Contraindications to fibrinolysis

References

Research

Door-to-balloon time in acute ST segment elevation myocardial infarction--further experience.

Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.